PA
AMAG

Pinnacle Associates’s AMAG Pharmaceuticals AMAG Stock Holding History

Pinnacle Associates’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-95,854
Closed -$3.81M – 677
2015
Q3 		$3.81M Sell
95,854
-2,091
-2% -$130K 0.08% 217
2015
Q2 		$6.76M Sell
97,945
-31,960
-25% -$2.01M 0.13% 165
2015
Q1 		$7.1M Buy
129,905
+375
+0.3% +$17.9K 0.13% 164
2014
Q4 		$5.52M Buy
+129,530
New +$4.68M 0.11% 183

Other funds holding AMAG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Pinnacle Associates's AMAG Position: Q4 2015 in Review

Pinnacle Associates sold out of AMAG Pharmaceuticals (AMAG) in Q4 2015, closing a stake of 95,854 shares — an estimated $3.81M sold.

Pinnacle Associates first reported a position in AMAG in Q4 2014 and held it in 4 quarters. The position peaked at $7.1M in Q1 2015. 172 funds tracked by Wall St. Rank hold AMAG as of Q4 2015.

  • Pinnacle Associates reported no remaining AMAG Pharmaceuticals position as of Q4 2015 after selling out during the quarter.
  • Pinnacle Associates sold 95,854 AMAG Pharmaceuticals shares in Q4 2015, an estimated $3.81M.
  • Pinnacle Associates first reported a position in AMAG Pharmaceuticals in Q4 2014 and held it in 4 quarters.
  • Pinnacle Associates's AMAG Pharmaceuticals position peaked at $7.1M in Q1 2015.
  • 172 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q4 2015.

Based on Pinnacle Associates's 13F filing for Q4 2015, filed 9 Feb 2016.